Thomas Cunningham, APRN
Psychiatric/Mental Health · Rogers, ARNPI 1578780946
Payments from drug & device makers
Across 131 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$632
- AbbVie$376
- Otsuka America Pharmaceutical, Inc.$239
- Vanda Pharmaceuticals Inc.$208
- Teva Pharmaceuticals USA, Inc.$185
- Alkermes, Inc.$164
- plus $439 from 6 others
What the payments were for
- Food & beverage$2,242100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $632 |
| AbbVie | 29 | $376 |
| Otsuka America Pharmaceutical, Inc. | 12 | $239 |
| Vanda Pharmaceuticals Inc. | 10 | $208 |
| Teva Pharmaceuticals USA, Inc. | 8 | $185 |
| Alkermes, Inc. | 9 | $164 |
| Axsome Therapeutics, Inc. | 7 | $133 |
| Lundbeck LLC | 4 | $81 |
| Corium, LLC | 3 | $75 |
| Johnson & Johnson | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
How this compares
$2,242 in reported general payments places this provider in the 75th percentile of 359 psychiatric/mental health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $609 |
| Duloxetine Hcl | 19 | $543 |
| Clonazepam | 38 | $499 |
| Bupropion XlBupropion Hcl | 26 | $486 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $418 |
| Hydroxyzine Hcl | 17 | $322 |
| Escitalopram Oxalate | 35 | $301 |
| Sertraline Hcl | 25 | $182 |
| Lorazepam | 25 | $160 |
| Mirtazapine | 13 | $156 |
| Buspirone Hcl | 11 | $99 |
| Fluoxetine Hcl | 29 | $67 |
| Trazodone Hcl | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Rogers
- Connor ClouserRogers$6K
- Alicia WilliamsRogers$5K
- Caden MiddletonRogers$5K
- Jason SeedRogers$4K
- Miriam KoesyRogers$4K
- Grayson BridgerRogers$4K
- Lisa FieldsRogers$3K
- Jahnneliz JonesRogers$3K
- Christie KellerFayetteville$167K
- Stephanie BohannonFayetteville$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.